Publication | Closed Access

Lipid nanoparticles loaded with ribonucleoprotein–oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibition

NanoparticlesEngineeringMedicineLipid NanoparticlesRibonucleoprotein–oligonucleotide ComplexesVirologyGene DeliveryBiomedical EngineeringMicrofluidicsNanodiscBiomolecular Engineering